Clinical Trials Browser

Terminated × Interventional × Basal Cell Nevus Syndrome × Clear all

NCT04308395 2024-09-24

Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)

Phase 3 Terminated

108 enrolled 12 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell

NCT04155190 2023-05-31

An Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCC

Phase 2 Terminated

Rombo syndrome, Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Syndrome, Xeroderma Pigmentosum

NCT02303041 2019-01-29

Pilot Study of Sonidegib and Buparlisib in Treating Patients With Advanced or Metastatic Basal Cell Carcinoma

Phase 2 Terminated

10 enrolled 11 charts

Basal Cell Nevus Syndrome, Carcinoma, Basal Cell, Skin Neoplasms

NCT02002689 2016-05-02

SIGNATURE

Phase 2 Terminated

10 enrolled 9 charts

DermatologicGastrointestinalGynecologicOther hematologic neoplasm

Basal Cell Nevus Syndrome, Colonic Neoplasms, Endometrial Neoplasms, Hematologic Neoplasms

NCT00049959 2011-03-16

Two Studies to Determine if Verteporfin PDT is Effective & Safe in Treating Multiple Basal Cell Carcinoma of the Skin.

Phase 3 Terminated

Basal cell carcinoma, multiple, Basal Cell Nevus Syndrome, Carcinoma, Basal Cell